Home › Companies › LARIMAR THERAPEUTICS, INC. › 2025-2026

LARIMAR THERAPEUTICS, INC. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and LARIMAR THERAPEUTICS, INC.’s Form 8-K, filed May 19, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 8Reported items
  • 150Asset managers
  • 1,248Fund votes
  • May 19, 2026Meeting date

Results at a glance

Meeting of May 19, 2026: 7 items on LARIMAR THERAPEUTICS, INC.’s Form 8-K, filed May 19, 2026: 4 approved · 3 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore LARIMAR THERAPEUTICS, INC. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by LARIMAR THERAPEUTICS, INC.

These tallies are LARIMAR THERAPEUTICS, INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 19, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

LARIMAR THERAPEUTICS, INC. — official shareholder meeting results, meeting held May 19, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Frank Thomas 66,827,378---- 8,569,29815,489,254 89%Not verified—
Elect Director: Carole S. Ben-Maimon, M.D. 67,314,208---- 8,082,46815,489,254 89%Not verified—
Elect Director: Joseph Truitt 66,445,617---- 8,951,05915,489,254 88%Not verified—
2. Approval, on an advisory basis, of the compensation of the Company's named executive officers in 2025 73,822,2371,498,42976,010 --15,489,254 98%Approved—
4. Ratification of Independent Registered Public Accountant 90,784,65172,97228,307 --0 99.9%Approved—
5. Approval of an amendment to the Ninth Amended and Restated Certificate of Incorporation, as amended 89,732,4861,046,555106,889 --0 99%Approved—
6. Approval of an adjournment of the Annual Meeting 89,887,684958,76139,485 --0 99%Approved—

Source: LARIMAR THERAPEUTICS, INC., Form 8-K, filed with the SEC on May 19, 2026 — read the filing on EDGAR.

How asset managers voted at the LARIMAR THERAPEUTICS, INC. 2025-2026 meeting

Each item below shows how the 150 asset managers that disclosed a LARIMAR THERAPEUTICS, INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LARIMAR THERAPEUTICS, INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Carole S. Ben-Maimon, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 67,314,208WITHHELD: 8,082,468
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: Election of Class III Directors for a Three-Year Term Expiring in 2029: Carole S. Ben-Maimon, M.D.

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Elect Director: Carole S. Ben-Maimon, M.D.”): 67,314,208 for, 8,082,468 withheld, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 7,219,909 for, 857,779 withheld, 6 abstained.

FOR
FOR: 7,219,909ABSTAIN: 6WITHHOLD: 857,779
Largest asset managers voting on “Election of Class III Directors for a Three-Year Term Expiring in 2029: Carole S. Ben-Maimon, M.D.” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,094,1520 62,996For
BlackRock1,667,4830 00For
Fidelity950,7150 00For
TIAA382,1360 00For
DRIEHAUS MUTUAL FUNDS00 0341,778Withhold
Goldman Sachs329,4630 00For
RBB FUND, INC.00 0164,782Withhold
JPMorgan158,5820 00For
Charles Schwab145,3420 00For
Equitable123,2360 00For
Dimensional00 0118,232Withhold
QUANTITATIVE MASTER SERIES LLC70,0680 00For
Brighthouse53,4530 015,492Mixed
Brinker Capital Destinations Trust1,7370 057,080Withhold
AIG/SunAmerica00 052,185Withhold
Nationwide40,0290 00For
BRIDGEWAY FUNDS INC00 034,916Withhold
Lincoln Financial31,2000 00For
Federated Hermes29,2570 00For
SEI24,9220 00For
Global X23,0430 00For
American Century00 020,071Withhold
Bridge Builder Trust19,8430 00For
Pacific Life19,6320 00For
State Street16,5460 00For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

2. Elect Director: Frank Thomas

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 66,827,378WITHHELD: 8,569,298
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: Election of Class III Directors for a Three-Year Term Expiring in 2029: Frank Thomas

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Elect Director: Frank Thomas”): 66,827,378 for, 8,569,298 withheld, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 6,790,824 for, 1,286,864 withheld, 6 abstained.

FORWITHHOLD
FOR: 6,790,824ABSTAIN: 6WITHHOLD: 1,286,864
Largest asset managers voting on “Election of Class III Directors for a Three-Year Term Expiring in 2029: Frank Thomas” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,092,7530 64,395For
BlackRock1,667,4830 00For
Fidelity950,7150 00For
TIAA00 0382,136Withhold
DRIEHAUS MUTUAL FUNDS00 0341,778Withhold
Goldman Sachs329,4630 00For
RBB FUND, INC.00 0164,782Withhold
JPMorgan158,5820 00For
Charles Schwab145,3420 00For
Equitable77,6860 045,550Mixed
Dimensional00 0118,232Withhold
QUANTITATIVE MASTER SERIES LLC70,0680 00For
Brighthouse53,4530 015,492Mixed
Brinker Capital Destinations Trust1,7370 057,080Withhold
AIG/SunAmerica00 052,185Withhold
Nationwide40,0290 00For
BRIDGEWAY FUNDS INC00 034,916Withhold
Lincoln Financial31,2000 00For
Federated Hermes29,2570 00For
SEI24,9220 00For
Global X23,0430 00For
American Century00 020,071Withhold
Bridge Builder Trust19,8430 00For
Pacific Life19,6320 00For
State Street16,5460 00For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

3. Elect Director: Joseph Truitt

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 66,445,617WITHHELD: 8,951,059
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: Election of Class III Directors for a Three-Year Term Expiring in 2029: Joseph Truitt

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Elect Director: Joseph Truitt”): 66,445,617 for, 8,951,059 withheld, per its Form 8-K filed May 19, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 6,773,025 for, 1,304,663 withheld, 6 abstained.

FORWITHHOLD
FOR: 6,773,025ABSTAIN: 6WITHHOLD: 1,304,663
Largest asset managers voting on “Election of Class III Directors for a Three-Year Term Expiring in 2029: Joseph Truitt” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,092,7530 64,395For
BlackRock1,667,4830 00For
Fidelity950,7150 00For
TIAA00 0382,136Withhold
DRIEHAUS MUTUAL FUNDS00 0341,778Withhold
Goldman Sachs329,4630 00For
RBB FUND, INC.00 0164,782Withhold
JPMorgan158,5820 00For
Charles Schwab145,3420 00For
Equitable77,6860 045,550Mixed
Dimensional00 0118,232Withhold
QUANTITATIVE MASTER SERIES LLC70,0680 00For
Brighthouse53,4530 015,492Mixed
Brinker Capital Destinations Trust1,7370 057,080Withhold
AIG/SunAmerica00 052,185Withhold
Nationwide40,0290 00For
BRIDGEWAY FUNDS INC00 034,916Withhold
Lincoln Financial31,2000 00For
Federated Hermes29,2570 00For
SEI24,9220 00For
Global X23,0430 00For
American Century00 020,071Withhold
Bridge Builder Trust19,8430 00For
Pacific Life19,6320 00For
State Street16,5460 00For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

4. 5. Approval of an amendment to the Ninth Amended and Restated Certificate of Incorporation, as amended

Official resultCAPITAL STRUCTUREReported outcome: Approved

99% Approved · of votes cast

FOR 99%
FOR: 89,732,486AGAINST: 1,046,555
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: APPROVAL OF AN AMENDMENT TO OUR NINTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK FROM 115,000,000 TO 215,000,000.

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“5. Approval of an amendment to the Ninth Amended and Restated Certificate of Incorporation, as amended”): 89,732,486 for, 1,046,555 against — passed, per its Form 8-K filed May 19, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved an amendment to the Company's Ninth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's Common Stock from 115,000,000 to 215,000,000, as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 8,077,694 for.

FOR
FOR: 8,077,694
Largest asset managers voting on “APPROVAL OF AN AMENDMENT TO OUR NINTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREA” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,097,1540 00For
BlackRock1,667,4830 00For
Fidelity950,7150 00For
TIAA382,1360 00For
DRIEHAUS MUTUAL FUNDS341,7780 00For
Goldman Sachs329,4630 00For
RBB FUND, INC.164,7820 00For
JPMorgan158,5820 00For
Charles Schwab145,3420 00For
Equitable123,2360 00For
Dimensional118,2320 00For
QUANTITATIVE MASTER SERIES LLC70,0680 00For
Brighthouse68,9450 00For
Brinker Capital Destinations Trust58,8170 00For
AIG/SunAmerica52,1850 00For
Nationwide40,0290 00For
BRIDGEWAY FUNDS INC34,9160 00For
Lincoln Financial31,2000 00For
Federated Hermes29,2570 00For
SEI24,9220 00For
Global X23,0430 00For
American Century20,0710 00For
Bridge Builder Trust19,8430 00For
Pacific Life19,6320 00For
State Street16,5460 00For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

5. 6. Approval of an adjournment of the Annual Meeting

Official resultCORPORATE GOVERNANCEReported outcome: Approved

99% Approved · of votes cast

FOR 99%
FOR: 89,887,684AGAINST: 958,761
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING TO THE EXTENT THERE ARE INSUFFICIENT VOTES AT THE ANNUAL MEETING TO APPROVE PROPOSAL 5.

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“6. Approval of an adjournment of the Annual Meeting”): 89,887,684 for, 958,761 against — passed, per its Form 8-K filed May 19, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 6: Approval of an adjournment of the Annual Meeting”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 8,017,102 for, 60,592 against.

FOR
FOR: 8,017,102AGAINST: 60,592
Largest asset managers voting on “APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING TO THE EXTENT THERE ARE INSUFFICIENT VOTES AT THE ANNUAL MEET” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,097,1540 00For
BlackRock1,667,4830 00For
Fidelity950,7150 00For
TIAA382,1360 00For
DRIEHAUS MUTUAL FUNDS341,7780 00For
Goldman Sachs329,4630 00For
RBB FUND, INC.164,7820 00For
JPMorgan158,5820 00For
Charles Schwab145,3420 00For
Equitable123,2360 00For
Dimensional118,2320 00For
QUANTITATIVE MASTER SERIES LLC70,0680 00For
Brighthouse68,9450 00For
Brinker Capital Destinations Trust57,0801,737 00For
AIG/SunAmerica52,1850 00For
Nationwide40,0290 00For
BRIDGEWAY FUNDS INC34,9160 00For
Lincoln Financial031,200 00Against
Federated Hermes29,2570 00For
SEI24,9220 00For
Global X23,0430 00For
American Century20,0710 00For
Bridge Builder Trust19,8430 00For
Pacific Life19,6320 00For
State Street016,546 00Against

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

6. 2. Approval, on an advisory basis, of the compensation of the Company's named executive officers in 2025

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 73,822,237AGAINST: 1,498,429
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“2. Approval, on an advisory basis, of the compensation of the Company's named executive officers in 2025”): 73,822,237 for, 1,498,429 against — passed, per its Form 8-K filed May 19, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers in 2025, as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 45 asset managers voting on “Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,097,1531 00For
BlackRock1,667,4830 00For
Fidelity950,7150 00For
TIAA382,1360 00For
DRIEHAUS MUTUAL FUNDS341,7780 00For
Goldman Sachs329,4630 00For
RBB FUND, INC.164,7820 00For
JPMorgan0158,582 00Against
Charles Schwab145,3420 00For
Equitable123,2360 00For
Dimensional118,2320 00For
QUANTITATIVE MASTER SERIES LLC70,0680 00For
Brighthouse15,49253,453 00Mixed
Brinker Capital Destinations Trust58,8170 00For
AIG/SunAmerica52,1850 00For
Nationwide40,0290 00For
BRIDGEWAY FUNDS INC034,916 00Against
Lincoln Financial31,2000 00For
Federated Hermes29,2570 00For
SEI24,9220 00For
Global X23,0430 00For
American Century020,071 00Against
Bridge Builder Trust19,8430 00For
Pacific Life19,6320 00For
State Street16,5460 00For

Fund voting reports, all 45 managers: 7,800,164 for, 277,530 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 120 asset managers voting on “Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
DEERFIELD MANAGEMENT COMPANY, L.P.35,606,9740 00For
Blue Owl Capital Holdings LP7,120,0070 00For
AIGH Capital Management LLC2,139,8790 00For
DRIEHAUS CAPITAL MANAGEMENT LLC2,130,6210 00For
DAFNA Capital Management LLC2,029,1640 00For
RTW INVESTMENTS, LP1,500,0000 00For
Woodline Partners LP1,400,8500 00For
BlackRock1,338,69019,070 00For
Deep Track Capital, LP1,345,0920 00For
Logos Global Management LP1,299,9970 00For
GEODE CAPITAL MANAGEMENT, LLC1,106,5880 00For
Soleus Capital Management, L.P.888,4070 00For
Point72678,7620 00For
Alyeska Investment Group, L.P.0540,384 00Against
State Street495,3361,659 00For
Two Sigma440,1230 00For
Nuveen392,7090 00For
DE Shaw357,0500 00For
AQR331,7470 00For
Northern Trust320,2722,408 00For
MARSHALL WACE, LLP322,1750 00For
Vanguard318,2600 00For
Renaissance278,2090 00For
Goldman Sachs159,5870 00For
Charles Schwab145,3420 00For

Institutional-manager reports, all 120 managers: 63,975,497 for, 741,506 against, 3,289 abstained, 13,176 1 year. Showing the 25 largest; see all in the interactive database.

7. Approval, on an Advisory Basis, of the Preferred Frequency of Future Advisory Votes on the Compensation of our Named…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 147 asset managers

Description as filed by funds: Approval, on an Advisory Basis, of the Preferred Frequency of Future Advisory Votes on the Compensation of our Named Executive Officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 45 asset managers voting on “Approval, on an Advisory Basis, of the Preferred Frequency of Future Advisory Votes on the Compensation of our” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
BlackRock00 00--
Fidelity00 00--
TIAA00 00--
DRIEHAUS MUTUAL FUNDS00 00--
Goldman Sachs00 00--
RBB FUND, INC.00 00--
JPMorgan00 00--
Charles Schwab00 00--
Equitable00 00--
Dimensional00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
Brighthouse68,9450 00For
Brinker Capital Destinations Trust00 00--
AIG/SunAmerica00 00--
Nationwide00 00--
BRIDGEWAY FUNDS INC00 00--
Lincoln Financial00 00--
Federated Hermes00 00--
SEI00 00--
Global X00 00--
American Century00 00--
Bridge Builder Trust00 00--
Pacific Life00 00--
State Street00 00--

Fund voting reports, all 45 managers: 68,945 for, 7,885,712 1 year, 119,991 3 year, 3,046 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 117 asset managers voting on “Approval, on an Advisory Basis, of the Preferred Frequency of Future Advisory Votes on the Compensation of our” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
DEERFIELD MANAGEMENT COMPANY, L.P.00 00--
Blue Owl Capital Holdings LP00 00--
DRIEHAUS CAPITAL MANAGEMENT LLC00 00--
DAFNA Capital Management LLC00 00--
RTW INVESTMENTS, LP00 00--
BlackRock00 00--
Deep Track Capital, LP00 00--
Logos Global Management LP00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
Soleus Capital Management, L.P.00 00--
Point7200 00--
Alyeska Investment Group, L.P.00 00--
State Street00 00--
Two Sigma00 00--
Nuveen00 00--
DE Shaw00 00--
AQR00 00--
Northern Trust00 00--
MARSHALL WACE, LLP00 00--
Vanguard00 00--
Renaissance00 00--
Goldman Sachs00 00--
Charles Schwab00 00--
Citadel00 00--
MELLON INVESTMENTS Corp00 00--

Institutional-manager reports, all 117 managers: 13,176 for, 5,289 abstained, 61,027,176 1 year, 113,946 3 year, 33,000 unknown. Showing the 25 largest; see all in the interactive database.

8. 4. Ratification of Independent Registered Public Accountant

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 90,784,651AGAINST: 72,972
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: Ratification of Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for the 2026 Fiscal Year.

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“4. Ratification of Independent Registered Public Accountant”): 90,784,651 for, 72,972 against — passed, per its Form 8-K filed May 19, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was ratified, as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 8,077,694 for.

FOR
FOR: 8,077,694
Largest asset managers voting on “Ratification of Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,097,1540 00For
BlackRock1,667,4830 00For
Fidelity950,7150 00For
TIAA382,1360 00For
DRIEHAUS MUTUAL FUNDS341,7780 00For
Goldman Sachs329,4630 00For
RBB FUND, INC.164,7820 00For
JPMorgan158,5820 00For
Charles Schwab145,3420 00For
Equitable123,2360 00For
Dimensional118,2320 00For
QUANTITATIVE MASTER SERIES LLC70,0680 00For
Brighthouse68,9450 00For
Brinker Capital Destinations Trust58,8170 00For
AIG/SunAmerica52,1850 00For
Nationwide40,0290 00For
BRIDGEWAY FUNDS INC34,9160 00For
Lincoln Financial31,2000 00For
Federated Hermes29,2570 00For
SEI24,9220 00For
Global X23,0430 00For
American Century20,0710 00For
Bridge Builder Trust19,8430 00For
Pacific Life19,6320 00For
State Street16,5460 00For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Largest LARIMAR THERAPEUTICS, INC. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 103,882,937 shares outstanding at the time of that meeting.

Fund voting reports: top LARIMAR THERAPEUTICS, INC. shareholders by shares voted on “Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 2.98%
2BlackRock 1.61%
3Fidelity 0.92%
4TIAA 0.37%
5DRIEHAUS MUTUAL FUNDS 0.33%
6Goldman Sachs 0.32%
7RBB FUND, INC. 0.16%
8JPMorgan 0.15%
9Charles Schwab 0.14%
10Equitable 0.12%
Institutional-manager reports: top LARIMAR THERAPEUTICS, INC. shareholders by shares voted on “Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.”, 2025-2026
#Asset manager % of shares outstanding
1DEERFIELD MANAGEMENT COMPANY, L.P. 34.28%
2Blue Owl Capital Holdings LP 6.85%
3AIGH Capital Management LLC 2.06%
4DRIEHAUS CAPITAL MANAGEMENT LLC 2.05%
5DAFNA Capital Management LLC 1.95%
6RTW INVESTMENTS, LP 1.44%
7Woodline Partners LP 1.35%
8BlackRock 1.31%
9Deep Track Capital, LP 1.29%
10Logos Global Management LP 1.25%

Reported LARIMAR THERAPEUTICS, INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

LARIMAR THERAPEUTICS, INC. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Deerfield Management Company, L.P. 34.33% 13D
BlackRock 3.61% 13F
Millennium Management 3.49% 13F
Vanguard Group 2.93% 13F
Goldman Sachs 1.59% 13F
Geode Capital 1.07% 13F
Point72 1.01% 13F
State Street 0.88% 13F
Dimensional Fund Advisors 0.77% 13F
Renaissance Technologies 0.71% 13F

Percentages above are of 103,882,937 shares outstanding, as reported by LARIMAR THERAPEUTICS, INC. on its Form 10-Q dated May 12, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LARIMAR THERAPEUTICS, INC.’s 10-Q dated May 12, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At LARIMAR THERAPEUTICS, INC.'s shareholder meeting held May 19, 2026, in the 2025-2026 proxy season, 150 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,248 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. — LARIMAR THERAPEUTICS, INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: LARIMAR THERAPEUTICS, INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 19, 2026.

LARIMAR THERAPEUTICS, INC. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.